LINC00520 up-regulates SOX5 to promote cell proliferation and invasion by miR-4516 in human hepatocellular carcinoma
Author:
Li Qing1, Wang Wei2, Yang Tao2, Li Dongsheng2, Huang Yinpeng2, Bai Guang2, Li Qiang2
Affiliation:
1. Department of Internal Medicine , Third Affiliated Hospital of Jinzhou Medical University , Jinzhou 121000 , China 2. Department of General Surgery , First Affiliated Hospital of Jinzhou Medical University , Jinzhou 121000 , China
Abstract
Abstract
Hepatocellular carcinoma (HCC) is one of the most common human cancers. Long non-coding RNA (lncRNA) has been demonstrated to play an important role in regulating tumor development. The current study aims to explore the specific role of LINC00520 during HCC progression. The present study identified that LINC00520 was upregulated in HCC tissues and indicated poor patient survival. Overexpression of LINC00520 promoted HCC cell proliferation, migration and invasion, while LINC00520 downregulation led to the opposite effects. Besides, LINC00520 knockdown was found to inhibit tumor growth in vivo. Furthermore, LINC00520 acted as a sponge of miR-4516 to regulate SRY-related high mobility group box 5 (SOX5). In addition, the inhibition of miR-4516 partly reversed the inhibitory effect of LINC00520 silencing on HCC cell proliferation, migration and invasion. In conclusion, the inhibition of LINC00520 suppressed HCC cell proliferation, migration and invasion through mediating miR-4516/SOX5 axis. Therefore, our study provides a basis for the development of treatment strategies for HCC.
Funder
Liaoning Provincial Education Office FundLiaoning Provincial Science and Technology Department FundLiaoning Provincial Science and Technology Department Fund
Publisher
Walter de Gruyter GmbH
Subject
Clinical Biochemistry,Molecular Biology,Biochemistry
Reference34 articles.
1. Chen, R., Chen, Y., Huang, W., Zhao, Y., Luo, W., Lin, J., Wang, Z., and Yang, J. (2021). Comprehensive analysis of an immune-related ceRNA network in identifying a novel lncRNA signature as a prognostic biomarker for hepatocellular carcinoma. Aging 13: 17607–17628, https://doi.org/10.18632/aging.203250. 2. Chen, S., Xu, M., Zhao, J., Shen, J., Li, J., Liu, Y., Cao, G., Ma, J., He, W., Chen, X., et al.. (2020). MicroRNA-4516 suppresses pancreatic cancer development via negatively regulating orthodenticle homeobox 1. Int. J. Biol. Sci. 16: 2159–2169, https://doi.org/10.7150/ijbs.45933. 3. Chen, X., Fu, Y., Xu, H., Teng, P., Xie, Q., Zhang, Y., Yan, C., Xu, Y., Li, C., Zhou, J., et al.. (2018). SOX5 predicts poor prognosis in lung adenocarcinoma and promotes tumor metastasis through epithelial-mesenchymal transition. Oncotarget 9: 10891–10904, https://doi.org/10.18632/oncotarget.22443. 4. Chu, J., Geng, G., Ai, X., Jia, W., Wang, J., Xu, B., Kong, X., and Kong, L. (2021). LINC01291 promotes hepatocellular carcinoma development by targeting miR-186-5p/OXSR1 axis. J. Gene Med.: e3394, https://doi.org/10.1002/jgm.3394. 5. Cui, T., Bell, E.H., Mcelroy, J., Becker, A.P., Gulati, P.M., Geurts, M., Mladkova, N., Gray, A., Liu, K., Yang, L., et al.. (2019). miR-4516 predicts poor prognosis and functions as a novel oncogene via targeting PTPN14 in human glioblastoma. Oncogene 38: 2923–2936, https://doi.org/10.1038/s41388-018-0601-9.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|